David Coman - Science 37 CEO Director
| SNCEDelisted Stock | USD 0.28 0.02 7.69% |
Insider
David Coman is CEO Director of Science 37 Holdings
| Age | 54 |
| Phone | 984 377 3737 |
| Web | https://www.science37.com |
Science 37 Management Efficiency
The company has return on total asset (ROA) of (0.2831) % which means that it has lost $0.2831 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1852) %, meaning that it created substantial loss on money invested by shareholders. Science 37's management efficiency ratios could be used to measure how well Science 37 manages its routine affairs as well as how well it operates its assets and liabilities.Science 37 Holdings currently holds 1.32 M in liabilities with Debt to Equity (D/E) ratio of 0.01, which may suggest the company is not taking enough advantage from borrowing. Science 37 Holdings has a current ratio of 6.19, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Science 37's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Helen Hrdy | National Research Corp | 59 | |
| David Terrell | Forian Inc | N/A | |
| Thyagarajan Ramachandran | Healthcare Triangle | 48 | |
| Andrew Douglas | Forian Inc | N/A | |
| Michael Gill | Healthcare Triangle | 46 | |
| Lawrence FACS | Nutex Health | 75 | |
| Michael Vesey | Forian Inc | 62 | |
| Adam Dublin | Forian Inc | 58 | |
| Shibu Kizhakevilayil | Healthcare Triangle | 52 | |
| Lakshmanan Kannappan | Healthcare Triangle | 57 | |
| Jon Boumstein | National Research Corp | N/A | |
| Gregory MS | National Research Corp | N/A | |
| Steven Sobak | EUDA Health Holdings | 78 | |
| Kristi Lane | Healthcare Triangle | N/A | |
| Daniel Tan | EUDA Health Holdings | 43 | |
| Jona Raasch | National Research Corp | 65 | |
| Jim Grauel | FOXO Technologies | N/A | |
| Brian Chen | FOXO Technologies | N/A | |
| Robert Potashnick | FOXO Technologies | N/A | |
| Jon Bates | Nutex Health | 54 | |
| Daniel Barton | Forian Inc | 59 | |
Management Performance
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 |
Science 37 Holdings Leadership Team
Elected by the shareholders, the Science 37's board of directors comprises two types of representatives: Science 37 inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Science. The board's role is to monitor Science 37's management team and ensure that shareholders' interests are well served. Science 37's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Science 37's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Troy Bryenton, Chief Officer | ||
| Christine JD, Chief Secretary | ||
| David Coman, CEO Director | ||
| Mike Zaranek, Chief Officer | ||
| Elisa Cascade, Chief Officer | ||
| Christopher Ceppi, Chief Officer | ||
| Margie Kooman, Vice Communications | ||
| Michael Shipton, Chief Officer | ||
| Irena Lambridis, VP Compliance | ||
| Drew Bustos, Chief Officer | ||
| James Young, Chief Officer | ||
| Darcy Forman, Chief Officer | ||
| Tyler Horn, VP Staff | ||
| Jonathan MD, Chief Officer |
Science Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Science 37 a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.19 | |||
| Return On Asset | -0.28 | |||
| Profit Margin | (2.07) % | |||
| Operating Margin | (0.60) % | |||
| Current Valuation | (21.22 M) | |||
| Shares Outstanding | 6.03 M | |||
| Shares Owned By Insiders | 16.89 % | |||
| Shares Owned By Institutions | 52.18 % | |||
| Number Of Shares Shorted | 13.83 K | |||
| Price To Book | 0.67 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Science Stock
If you are still planning to invest in Science 37 Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Science 37's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |